Everest Organics Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO currently assigns Everest Organics Ltd a 'Sell' rating, indicating a cautious stance towards the stock. This rating suggests that investors should consider reducing exposure or avoiding new positions in the stock, given the prevailing fundamentals and market conditions. The 'Sell' grade reflects a combination of factors including quality, valuation, financial trends, and technical indicators, which collectively point to limited upside potential and elevated risks.

Quality Assessment: Below Average Fundamentals

As of 06 July 2026, Everest Organics exhibits below average quality metrics. The company has experienced a negative compound annual growth rate (CAGR) of -7.30% in operating profits over the past five years, signalling a persistent decline in core earnings. This weak long-term fundamental strength raises concerns about the company’s ability to generate sustainable profits.

Further, Everest Organics’ average Return on Equity (ROE) stands at a modest 2.02%, indicating low profitability relative to shareholders’ funds. This level of ROE suggests that the company is not efficiently deploying capital to generate returns, which is a critical consideration for investors seeking value creation.

Debt servicing capacity also appears constrained, with a Debt to EBITDA ratio of 2.52 times. This relatively high leverage ratio implies increased financial risk, especially in a sector where stable cash flows are essential to meet obligations. The operating profit to interest coverage ratio for the latest quarter is 2.43 times, which is on the lower side, further underscoring the company’s limited cushion to absorb interest expenses.

Valuation: Very Attractive but Requires Caution

Despite the challenges in quality metrics, Everest Organics is currently valued very attractively. The valuation grade reflects a stock price that is low relative to earnings and book value, potentially offering a margin of safety for investors. This valuation attractiveness may appeal to value-oriented investors who are willing to tolerate near-term risks in anticipation of a turnaround.

However, it is important to note that attractive valuation alone does not guarantee positive returns, especially when underlying fundamentals remain weak. Investors should weigh the valuation benefits against the company’s operational and financial challenges before making investment decisions.

Financial Trend: Flat Performance with Recent Weakness

The financial trend for Everest Organics is currently flat, reflecting stagnation rather than growth. The latest six-month profit after tax (PAT) stands at ₹2.99 crores, representing a decline of 26.17% compared to the previous period. This contraction in profitability highlights ongoing operational difficulties.

Additionally, the company’s debtor turnover ratio for the half year is 1.63 times, which is relatively low and may indicate inefficiencies in collecting receivables. Such inefficiencies can strain working capital and cash flow, further complicating the financial outlook.

Technicals: Mildly Bearish Momentum

From a technical perspective, Everest Organics exhibits mildly bearish signals. While the stock has shown some short-term gains—rising 6.58% over the past week and 13.25% over the last month—the longer-term trend remains negative. Over six months, the stock has declined by 47.26%, and year-to-date losses stand at 46.53%. The one-year return is down 20.01%, reflecting sustained selling pressure.

These technical indicators suggest that despite occasional rallies, the stock faces downward momentum, which may limit near-term upside and increase volatility risk for investors.

Here’s How Everest Organics Looks Today

As of 06 July 2026, Everest Organics Ltd remains a microcap player in the Pharmaceuticals & Biotechnology sector, with a Mojo Score of 31.0, categorised under the 'Sell' grade. This score represents a slight improvement from the previous 'Strong Sell' rating, which was adjusted on 24 June 2026, reflecting a modest positive shift in the company’s outlook.

However, the overall picture remains cautious. The company’s weak long-term growth, low profitability, and financial constraints weigh heavily against the stock. While valuation metrics are appealing, they are counterbalanced by operational challenges and subdued technical momentum.

Investors should interpret the 'Sell' rating as a signal to approach Everest Organics with prudence. The current rating advises that the risks outweigh the potential rewards at this juncture, and that capital preservation should be prioritised over speculative gains.

Investor Takeaway

For investors considering Everest Organics Ltd, the current 'Sell' rating from MarketsMOJO serves as a cautionary guide. The company’s below average quality metrics and flat financial trend suggest limited growth prospects in the near term. Although the stock’s valuation is very attractive, it is essential to recognise that value alone does not offset the risks posed by weak fundamentals and financial leverage.

Technical indicators reinforce this cautious stance, with the stock exhibiting mildly bearish momentum despite some short-term gains. This combination of factors implies that investors should carefully evaluate their risk tolerance and investment horizon before engaging with this stock.

In summary, Everest Organics Ltd’s current rating reflects a comprehensive assessment of its operational challenges, financial health, valuation appeal, and market sentiment. The 'Sell' recommendation advises investors to prioritise capital protection and consider alternative opportunities with stronger fundamentals and more favourable technical profiles.

Sector Context and Market Position

Operating within the Pharmaceuticals & Biotechnology sector, Everest Organics faces intense competition and regulatory pressures that can impact profitability and growth. The microcap status of the company further adds to liquidity concerns and volatility risks. Investors should consider these sector-specific dynamics alongside the company’s individual performance metrics when making portfolio decisions.

Given the current market environment and Everest Organics’ financial profile, the 'Sell' rating aligns with a prudent investment approach, signalling that the stock may underperform relative to peers and broader market indices.

Summary of Key Metrics as of 06 July 2026

• Mojo Score: 31.0 (Sell Grade)
• Operating Profit CAGR (5 years): -7.30%
• Return on Equity (avg): 2.02%
• Debt to EBITDA Ratio: 2.52 times
• PAT (Latest 6 months): ₹2.99 crores, down 26.17%
• Operating Profit to Interest Coverage (Quarterly): 2.43 times
• Debtors Turnover Ratio (Half Year): 1.63 times
• Stock Returns: 1D: 0.00%, 1W: +6.58%, 1M: +13.25%, 3M: +17.48%, 6M: -47.26%, YTD: -46.53%, 1Y: -20.01%

These figures collectively underpin the current 'Sell' rating and provide a data-driven foundation for investors to assess the stock’s risk-reward profile.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today